Top Injectable Manufacturer in Turkey – Reliable Pharmaceutical Solutions
- Maulik Sudani
- 15 hours ago
- 8 min read
Last Updated: July 12, 2026
TL;DR: Turkey — a nation of more than 86 million people bridging Europe and Asia, with one of the strongest domestic pharmaceutical industries in the region and an assertive localisation (yerlileştirme) policy — produces most of its medicines locally, yet still imports a significant share of specialised sterile injectables, oncology and biotechnology products and a large proportion of its active pharmaceutical ingredients. Every imported sterile injectable must hold a marketing authorisation (ruhsat) issued by the Turkish Medicines and Medical Devices Agency (TİTCK) under the Ministry of Health, be represented by a local authorisation holder, be filed in CTD/eCTD format, be supported by a Certificate of Pharmaceutical Product, pass TİTCK's own good-manufacturing-practice assessment of the manufacturing site, carry Turkish-language labelling and be enrolled in the İTS (İlaç Takip Sistemi) track-and-trace system. Farbe Firma Pvt Ltd is a WHO-GMP certified injectable manufacturer in Turkey's supply chain and a CDMO in Gujarat, India, producing more than 100 sterile injectables under ISO Class 5 aseptic conditions and exporting to 30+ countries, with complete CTD/eCTD dossiers, drug master files and ICH stability data ready to support TİTCK registration, API supply and contract-manufacturing and technology-transfer partnerships for Turkish companies.
Key Takeaways
Market and regulatory pathway: every imported sterile injectable must hold a marketing authorisation (ruhsat) from the Turkish Medicines and Medical Devices Agency (TİTCK), be represented by a local authorisation holder, be filed in CTD/eCTD format, be backed by a Certificate of Pharmaceutical Product, pass TİTCK's own GMP inspection of the manufacturing site, carry Turkish labelling and be enrolled in the İTS (İlaç Takip Sistemi) track-and-trace system; Farbe Firma builds every dossier and supply arrangement around TİTCK requirements and Turkey's localisation (yerlileştirme) policy.
Certified manufacturing: WHO-GMP certified plant with an ISO Class 5 aseptic core, validated water-for-injection loops, terminal moist-heat sterilisation where the formulation qualifies and full aseptic processing where it does not, HPLC and LAL testing and 100% visual inspection on every batch.
CTD dossier and API support: full CTD/eCTD modules, ICH Q1A long-term and accelerated stability and ICH Q1B photostability data generated for Climatic Zone II, sterilisation and container-closure packages, drug master files and Certificate-of-Pharmaceutical-Product documentation for TİTCK marketing authorisation — plus active pharmaceutical ingredient supply for Turkey's large domestic manufacturing base.
End-to-end CDMO and technology transfer: contract and third-party manufacturing and technology-transfer support across 100+ sterile injectables — ampoules, vials, lyophilised products and pre-filled presentations — with Turkish artwork and leaflets, İTS-compliant serialised packaging and import/export coordination to Istanbul, Mersin and İzmir.
Introduction: Why an Injectable Manufacturer in Turkey Must Meet Global Standards
Turkey is one of the largest pharmaceutical markets bridging Europe and the Middle East, serving more than 86 million people through a broad public and private health system, and it is notable in the region for the strength of its domestic pharmaceutical industry, which supplies the great majority of the medicines the country consumes by volume. Across its social-security-funded hospitals, its university teaching hospitals and its specialist oncology and transplant centres the demand for sterile injectables is immense — antibiotics, anaesthetics, emergency and critical-care drugs, oncology therapies, analgesics, anti-emetics and maternal-health products. Every one of them has to reach hospitals and clinics sterile, correctly labelled and exactly to specification, batch after batch, whether it is destined for a teaching hospital in Istanbul, Ankara or İzmir or a regional state hospital across Anatolia.
Even with that strong domestic base and an assertive localisation (yerlileştirme) policy that actively encourages local production, Turkey still imports a significant share of its specialised sterile injectables, oncology and biotechnology products and the raw materials behind them, relying on imports for a large proportion of its active pharmaceutical ingredients — which makes reliable overseas manufacturing and API partners strategically important. Any imported product must clear a demanding regulatory pathway: every medicine must hold a marketing authorisation, the ruhsat, issued by the Turkish Medicines and Medical Devices Agency (TİTCK) under the Ministry of Health; a local authorisation holder must file and maintain the registration; the dossier must be prepared in CTD/eCTD format and submitted through the TİTCK electronic system; the manufacturing site must satisfy WHO-GMP and, distinctively, be inspected directly by TİTCK, which conducts its own good-manufacturing-practice assessments of foreign sites rather than simply accepting a foreign certificate, and be documented with a Certificate of Pharmaceutical Product; the labelling and patient leaflet must be translated into Turkish; and every pack must be serialised for the İTS track-and-trace system. An injectable manufacturer that wants to serve Turkey well has to treat these requirements not as afterthoughts but as core design inputs — which is exactly how Farbe Firma approaches the market.
What Sets a World-Class Injectable Manufacturer in Turkey Apart
The first differentiator is genuine sterile-manufacturing capability. A world-class injectable manufacturer serving Turkey runs a WHO-GMP certified plant with an ISO Class 5 (Grade A) aseptic core, validated water-for-injection generation and looped distribution, qualified HVAC with continuous environmental monitoring, and both terminal moist-heat sterilisation and full aseptic processing so that each product is made by the route its formulation and container actually justify. It backs that with a proper analytical laboratory — stability-indicating HPLC assay and related-substance control, bacterial endotoxin testing by LAL, sterility testing, and particulate and container-closure-integrity checks — and a broad portfolio of more than 100 injectables in ampoule, vial, lyophilised and pre-filled formats, so a Turkish authorisation holder, hospital or manufacturing partner can consolidate many finished-product and API needs with a single qualified source. Because TİTCK inspects foreign sites directly, a manufacturer that is used to hosting stringent regulatory inspections is a genuine asset.
The second differentiator is registration, API and partnership support built specifically around Turkey. Because TİTCK reviews dossiers in CTD/eCTD format, a strong partner prepares complete, review-ready modules with ICH Q1A stability and ICH Q1B photostability data, drug master files, sterilisation and container-closure reports, method-validation packages and a Certificate of Pharmaceutical Product — the documentation a local authorisation holder's regulatory team needs to obtain a ruhsat without gaps or delays, and to prepare the site for TİTCK's own on-site GMP inspection. Because Turkey's own manufacturers are so capable and the localisation policy rewards local production, the most valuable partner also offers active pharmaceutical ingredients, bulk and semi-finished supply, and contract-manufacturing and technology-transfer arrangements that let Turkish companies fill, finish or formulate locally. It supplies Turkish artwork and package inserts and structures every pack for İTS serialisation. This combination of manufacturing depth, API supply and Turkey-specific dossier and partnership support is what separates a true injectable manufacturer in Turkey's supply chain from a mere exporter.
Quality Systems Behind Every Batch We Ship to Turkey
Every Farbe Firma injectable batch destined for Turkey is released only after a full stack of quality checks: stability-indicating HPLC assay against pharmacopoeial reference standards, control of related substances and degradation products, solution pH and clarity, deliverable volume, visible and sub-visible particulate matter, bacterial endotoxin by LAL, sterility by membrane filtration, and container-closure integrity for the ampoule, vial or pre-filled format. Certificates of analysis are issued with full traceability back to each API lot, the primary-packaging lot and the qualified person responsible for release, so a local authorisation holder's regulatory-affairs team and TİTCK reviewers and inspectors can see a complete, auditable chain from raw material to finished unit.
Around those release tests sits a deeper quality architecture: validated water-for-injection systems, qualified and monitored cleanrooms, validated sterilisation and depyrogenation equipment, validated filling lines with 100% inspection, and an electronic batch-record system tied into formal deviation, change-control and CAPA workflows. Stability is tracked under long-term (25 °C / 60 % RH, the ICH Climatic Zone II condition appropriate to Turkey's temperate Mediterranean and continental climate), intermediate (30 °C / 65 % RH) and accelerated (40 °C / 75 % RH) conditions, with a photostability challenge where relevant, so registered shelf lives are supported by data generated under conditions that reflect how the product will actually be stored and transported — from the ports of Istanbul, Mersin and İzmir to hospitals across Anatolia.
Looking for a sterile injectable manufacturing partner? Submit a Quick Inquiry
Why Farbe Firma is the Trusted Injectable Manufacturer in Turkey for Global Buyers
Farbe Firma Pvt Ltd manufactures more than 100 sterile injectables at its WHO-GMP certified facility in Gujarat, India, spanning antibiotic, anaesthesia, emergency and critical-care, gastrointestinal, anti-emetic, analgesic, vitamin and specialty ranges — the categories Turkish hospitals, importers and manufacturers need most, including the specialty and critical-care injectables and the active pharmaceutical ingredients that complement Turkey's strong domestic production. For Turkish partners we supply finished sterile injectables ready for TİTCK registration, along with API and bulk supply, with market-specific strengths, fill volumes, Turkish artwork and İTS-serialised tamper-evident packs available under contract-manufacturing agreements, and every batch released to WHO-GMP standards with its CTD data package and Certificate of Pharmaceutical Product ready for the authorisation holder's ruhsat filing.
Our CDMO services scale cleanly from a single importer's launch portfolio to long-term API supply and technology-transfer partnerships with Turkish manufacturers — an approach that sits naturally alongside Turkey's localisation policy. We prepare complete CTD/eCTD modules, drug master files, ICH Q1A stability and ICH Q1B photostability packages, assay and related-substance method-validation data, sterilisation and container-closure reports, a Certificate of Pharmaceutical Product, and translated Turkish inserts and artwork. Our regulatory, manufacturing and logistics teams coordinate registration timelines, TİTCK GMP-inspection hosting, line slots and shipping to Istanbul, Mersin and İzmir as a single, managed programme rather than a series of disconnected transactions, and we structure documentation so that products carry the İTS serialisation the market requires.
Buyers stay with Farbe Firma because of audit-readiness and communication. Turkish importers, manufacturing partners and their auditors are welcomed onto the plant floor and into the compounding and filling suites; our quality unit answers technical and regulatory queries with primary data rather than slogans; and our reviewer team — practising pharmacists and R&D scientists — can talk through API sourcing, sterile-process design, stability strategy for a Zone II climate, CTD dossier structure, TİTCK ruhsat steps and GMP-inspection preparation, technology transfer and İTS serialisation in real detail. For an importer, hospital or manufacturer that has to answer to TİTCK, to the Social Security Institution (SGK) and to its own patients, that transparency is exactly what makes a distant manufacturer feel like a dependable local partner.
Explore Farbe Firma: Products | Global Reach | About Us
Frequently Asked Questions (FAQ)
Is Farbe Firma a WHO-GMP certified injectable manufacturer that can supply Turkey?
Yes. Farbe Firma Pvt Ltd holds WHO-GMP certification and manufactures more than 100 sterile injectables at its Gujarat, India facility with ISO Class 5 aseptic processing, validated water-for-injection systems, terminal and aseptic sterilisation routes, HPLC and LAL testing, 100% inspection and continuous environmental monitoring. We already export to 30+ countries and prepare every batch and dossier to support import and TİTCK marketing authorisation in Turkey through a local authorisation holder, alongside API supply and contract-manufacturing partnerships, and we are prepared to host TİTCK's own on-site GMP inspection.
How does Farbe Firma support TİTCK marketing authorisation (ruhsat) in Turkey?
We provide complete CTD/eCTD modules, drug master files, ICH Q1A stability (for Climatic Zone II) and ICH Q1B photostability data, sterilisation and container-closure reports, method-validation packages and a Certificate of Pharmaceutical Product — the technical documentation a local authorisation holder's regulatory team needs to obtain a ruhsat from the Turkish Medicines and Medical Devices Agency (TİTCK). We also supply Turkish artwork and package inserts, structure every pack for İTS serialisation, and prepare the manufacturing site for TİTCK's own GMP inspection.
Can Farbe Firma supply active pharmaceutical ingredients and technology transfer to Turkish manufacturers?
Yes. Because Turkey has a strong domestic pharmaceutical industry and a localisation policy that rewards local production, much of our value lies in supplying active pharmaceutical ingredients and bulk material, and in contract-manufacturing and technology-transfer partnerships that let Turkish companies formulate, fill or finish locally. We provide drug master files, method-validation packages and stability data to support local registration and manufacturing under TİTCK rules.
Which injectables can Farbe Firma supply to Turkish hospitals and importers?
Our portfolio of 100+ sterile injectables covers antibiotics, anaesthetics, emergency and critical-care drugs, analgesics, anti-emetics, gastrointestinal agents, vitamins and specialty products in ampoule, vial, lyophilised and pre-filled formats — with an emphasis on the specialty and critical-care injectables and APIs that complement Turkey's domestic production. Market-specific strengths and pack sizes are available under contract.
What is the minimum order quantity for injectable contract manufacturing for Turkey?
MOQs vary by product, format, sterilisation route, label complexity and dossier requirements. We accommodate single-importer launch quantities, bulk API supply and full technology-transfer partnerships for the Turkish market. Contact director@farbefirma.org for a specific quotation and a registration and supply plan for your product list.
Technically Reviewed By: Maulik Sudani | Jignasu Sudani (Technical Expert)
Website: www.farbefirma.org | Email: director@farbefirma.org | Address: Gujarat, INDIA
Request a Quote | View Products | FAQ | Blog
Comments